Pulmonary hypertension combination therapy may lead to greater disease burden
Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding ...
Oct 22, 2012
0
0